Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2009 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (256)	6/26/2009 5:02:41 PM
From: BulbaMan	Read Replies (1) \| Respond to of 418

6/26/09 update The Nasdaq Composite Index managed to eke out a small gain for the week, closing Friday up 16.97% CYTD, or Contest Year To Date, (vs. up 16.28% CYTD a week ago). However, biotech Bulls snorted more loudly, with the Nasdaq Biotech Index closing up 5.25% CYTD (vs. up 2.83% CYTD a week ago) and the Contest median closing up 18.07% CYTD (vs. up 14.34% CYTD a week ago). RKRW's portfolio held on first place, with GEORGIA's's portfolio and GENE's portfolio remaining in second and third place. Friday's closing CYTD percentages are: RKRW up 82.13%, GEORGIA up 68.33%, GENE up 62.90%. At Friday's close, an impressive 24 of the 32 Contest portfolios were in the black and 22 of the 32 were beating the NBI. Have a terrific weekend folks! Below is the Top Ten list on 6/26/09: 6/26/09 Rank Name Profit/Loss 1 RKRW 82,128 2 GEORGIA 68,326 3 GENE 62,897 4 MIKE 45,741 5 ROBERT 43,549 6 ENZYME 42,291 7 PRAVN 40,920 8 SCARAM 39,761 9 BULBA 35,303 10 MOPGCW 30,985 (All corrections, especially adjustments for splits, greatly appreciated.)